• About
    • Our Team
    • Clinical Advisory Board
    • Board of Directors
  • Product
  • Investors & Partners
  • News
  • Contact

News

Zucara Therapeutics & CDRD Complete Licensing Deal to Select Lead Therapeutic Drug Candidate

October 14, 2016 by zucaraadmin

This new license is an important step forward in bringing a new drug therapy closer to patients living with diabetes

read more

Zucara Therapeutics Appoints Michael Midmer as CEO

September 9, 2016 by zucaraadmin

VANCOUVER and TORONTO, Canada (September 9, 2016) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term

read more

World Health Day 2016: Beat diabetes

April 7, 2016 by zucaraadmin

The World Health Organization (WHO) has marked April 7, 2016 as World Health Day. The focus of this year’s theme

read more

Zucara Therapeutics selected to present at Dose of the Valley

February 2, 2016 by zucaraadmin

VANCOUVER, BC (February 2, 2016) — The Centre for Drug Research and Development (CDRD) announced today that two of its

read more

Zucara Therapeutics Inc. developing drug to prevent hypoglycemic episodes for people with diabetes

January 12, 2016 by zucaraadmin

TORONTO and VANCOUVER, CANADA (January 12, 2016) — A novel drug therapy to reduce the severity and frequency of hypoglycemic

read more
  • «Previous Page
  • 1
  • 2
  • 3
  • 4

OUR INVESTORS & PARTNERS







CATEGORIES

  • News

Copyright 2025 Zucara Therapeutics, all rights reserved.